In the current study, we identified a female patient with disease meeting the diagnostic criteria for PP-MS who carried a point mutation in PLP1 that resulted in an amino acid substitution at residue 30 of PLP (L30V). The gene discussed is PLP1; the disease is myeloid sarcoma.